Renin-angiotensin system blockers and COVID-19

類似資料

• Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
  著者:: Danser, A.H. Jan, 等
  出版事項: (2020)
• Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review
  著者:: Gault, Nathalie, 等
  出版事項: (2021)
• Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
  著者:: Gressens, Simon B., 等
  出版事項: (2021)
• Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
  著者:: Mancia, Giuseppe, 等
  出版事項: (2020)
• COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients
  著者:: Genet, Bastien, 等
  出版事項: (2020)